Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

ABCs of MOGAD

Claim This Podcast

by Siegel Rare Neuroimmune Assoc.

4 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

On January 5, 2026, all episodes of "Ask the Expert, ABCs of MOGAD, ABCs of NMOSD, ADEM Academy, and Community Meets Clinic" - past and present - will now be found in one feed called “SRNA Soundwaves” on all podcast streaming platforms. Make sure to subscribe to "Ask the Expert," which will be renamed “SRNA Soundwaves” on January 5th: https://creators.spotify.com/pod/profile/srna-ask-the-expert/ If you have questions about the upcoming change, please email: podcast@wearesrna.org "ABCs of MOGAD" brings together the latest information and research about all things MOG antibody disease (MOGAD).

Language

🇺🇲

Publishing Since

9/13/2024

Visit Website View on Apple Podcasts RSS Feed

1 verified contact email on file for ABCs of MOGAD

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

December 15, 2025

0201. Steroid Dependence

Dr. Eoin Flanagan discusses steroid dependence in MOG antibody disease, including how steroids reduce brain inflammation and the complications that arise when tapering dosage, in an interview with Krissy Dilger.

December 5, 2025

Jan. 5, 2026, this series is moving to the “SRNA Soundwaves” channel (previously "Ask the Expert")

This episode announces the consolidation of five SRNA podcast series into a single channel called “SRNA Soundwaves” for a more organized listener experience.

September 16, 2024

0102. Meteoroid and cosMOG Clinical Trials for MOGAD Treatments

In the “ABCs of MOGAD” episode titled, “Meteoroid and cosMOG Clinical Trials for MOGAD Treatments,” Krissy Dilger of SRNA was joined by Dr. Michael Levy. They described MOG antibody disease and its similarities to NMO and MS, explaining current therapeutic options [00:01:56]. Dr. Levy talked about the cosMOG clinical trial, detailing the mechanism and potential of rozanolixizumab, and the criteria for participation [00:04:54]. The discussion also covered the Meteoroid trial and satralizumab as a potential treatment for MOGAD, comparing its design and eligibility criteria with those of cosMOG [00:15:12]. Both trials are actively enrolling participants, with the aim of preventing disease relapses and further expanding treatment options in the future [00:20:50]. Michael Levy, MD, PhD is an Associate Professor of Neurology at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology & Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine with a focus on neuroscience. In 2009, Dr. Levy was appointed to the faculty as Assistant Professor at Johns Hopkins where he started the Neuromyelitis Optica Clinic and Research Laboratory and in 2019 he moved to the Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology. Clinically, Dr. Levy specializes in taking care of patients with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease, acute disseminated encephalomyelitis and optic neuritis. In addition to neuroimmunology clinics, Dr. Levy has a special interest in patients with superficial siderosis of the central nervous system. Dr. Levy is the principal investigator on several clinical studies and drug trials for all of these conditions. In the laboratory, Dr. Levy’s research focuses on the development of animal models of neuromyelitis optica and transverse myelitis with the goal of tolerization as a sustainable long-term treatment.

4 total episodes available

Recent guests on ABCs of MOGAD

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Dr Eoin Flanagan

Guest

See every guest on ABCs of MOGAD

Deep-dive analytics for ABCs of MOGAD

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is ABCs of MOGAD?: On January 5, 2026, all episodes of "Ask the Expert, ABCs of MOGAD, ABCs of NMOSD, ADEM Academy, and Community Meets Clinic" - past and present - will now be found in one feed called “SRNA Soundwaves” on all podcast streaming platforms. Make sure to subscribe to "Ask the Expert," which will be renamed “SRNA Soundwaves” on January 5th: https://creators.spotify.com/pod/profile/srna-ask-the-expert/

If you have questions about the upcoming change, please email: podcast@wearesrna.org

"ABCs of MOGAD" brings together the latest information and research about all things MOG antibody disease (MOGAD).
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.